CBC News Canada voices sex therapists and psychiatrists concerns over the FDAs decision to approve Flibanserin last week. Critics contend, “it’s an ineffectual pharmacological solution for a problem better treated with relationship counselling, sex therapy and behavioural changes.” Walid Gellad, the co-director of the Center for Pharmaceutical Policy and Prescribing adds, “I believe that it should be used by almost no one.”
-
FDA is a bad joke. Even the mainstream is starting to recognize the problem. I’ve seen comments on press releases and surprising many people call bs on it.
-
The FDA / US government has discovered the “dirty little secret of the two original educated professions” – it’s really profitable to have the psychiatrists gaslight and force medicate the masses.
-
-
Over the past two decades, the use of antidepressants has skyrocketed. One in 10 Americans now takes an antidepressant medication; among women in their 40s and 50s, the figure is one in four. – New York Times
Women are two and a half times more likely than men to take an antidepressant medication — and for many, it’s affecting their sex lives.
According to a Johns Hopkins health alert, 30 to 70 percent of people on an antidepressant will experience sexual problems as a side effect.
– Huffingtonpost
-
“According to a Johns Hopkins health alert, 30 to 70 percent of people on an antidepressant will experience sexual problems as a side effect. ”
That’s a FAR higher percentage than those who experience relief from their depression…so the drugs should actually be marketed as drugs to lower sex drive, rather than to fix depression. It is a primary effect, not a side effect.
I wonder how FDA would fare if it were to openly approve a drug for the destruction of people’s sex lives (and downstream their marriages and families), rather than do it by stealth as is currently the case.
And I wonder what the marketing campaign might look like.
-
